Journal of Biomedical and Clinical Research 15(2): 118-122, doi: 10.2478/jbcr-2022-0016
Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
expand article infoZornitsa V. Gorcheva
© Zornitsa Gorcheva.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits to copy and distribute the article for non-commercial purposes, provided that the article is not altered or modified and the original author and source are credited.
Citation: Gorcheva ZV (2022) Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer. Journal of Biomedical and Clinical Research 15(2): 118-122. https://doi.org/10.2478/jbcr-2022-0016
Open Access
Abstract
Gastric cancer is the fifth most common and third leading cause of cancer death worldwide. Patients with chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are at increased risk of developing gastric cancer (GC). It is common for CAG to precede IM, but the etiology of the two conditions is not always the same. Different scoring systems are used to assess HAG, MI, and GC risk, making it difficult to interpret results from investigations and management of these conditions.
Keywords
chronic atrophic gastritis, intestinal metaplasia, gastric precancerous lesion